Skip to main content

Articles

Page 37 of 88

  1. The differential sensitivity of cough to antitussive therapies implies the existence of heterogeneity in cough hypersensitivity, but how such heterogeneity is expressed across individual patients is poorly und...

    Authors: Li Long, Hongmei Yao, Jing Tian, Wei Luo, Xinxin Yu, Fang Yi, Qiaoli Chen, Jiaxing Xie, Nanshan Zhong, Kian Fan Chung and Kefang Lai
    Citation: Respiratory Research 2019 20:112
  2. Inhaled bradykinin (BK) has been reported to both sensitize and induce cough but whether BK can centrally sensitize the cough reflex is not fully established. In this study, using a conscious guinea-pig model ...

    Authors: Fajer Al-Shamlan and Ahmed Z. El-Hashim
    Citation: Respiratory Research 2019 20:110
  3. The differential diagnosis of paediatric respiratory conditions is difficult and suboptimal. Existing diagnostic algorithms are associated with significant error rates, resulting in misdiagnoses, inappropriate...

    Authors: Paul Porter, Udantha Abeyratne, Vinayak Swarnkar, Jamie Tan, Ti-wan Ng, Joanna M. Brisbane, Deirdre Speldewinde, Jennifer Choveaux, Roneel Sharan, Keegan Kosasih and Phillip Della
    Citation: Respiratory Research 2019 20:81
  4. Hypoxic pulmonary vasoconstriction (HPV) optimizes the match between ventilation and perfusion in the lung by reducing blood flow to poorly ventilated regions. Sepsis and endotoxemia impair HPV. We previously ...

    Authors: Bodil Petersen, Cornelius J. Busch, Grigorij Schleifer, Dominik Schaack, Felix Lasitschka, Kenneth D. Bloch, Donald B. Bloch and Fumito Ichinose
    Citation: Respiratory Research 2019 20:109
  5. Several recent clinical trials have assessed the effects of dupilumab in uncontrolled asthma, but reached no definite conclusion. We therefore conducted this meta-analysis to evaluate the overall efficacy and ...

    Authors: Xiao-feng Xiong, Min Zhu, Hong-xia Wu, Li-li Fan and De-yun Cheng
    Citation: Respiratory Research 2019 20:108
  6. Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a variable clinical course and high mortality. We used data from a large national US registry of patients with IPF to investigate relationships...

    Authors: Laurie Snyder, Megan L. Neely, Anne S. Hellkamp, Emily O’Brien, Joao de Andrade, Craig S. Conoscenti, Thomas Leonard, Shaun Bender, Mridu Gulati, Daniel A. Culver, Robert J. Kaner, Scott Palmer and Hyun Joo Kim
    Citation: Respiratory Research 2019 20:105
  7. Tumor chemo-resistance is a hallmark of malignant tumors as well as the major cause of poor survival rates in lung cancer. Transmembrane-4 L-six family member-1 (TM4SF1), an antigen that serves as an oncogene, ma...

    Authors: Lin Ye, Chunyun Pu, Jun Tang, Yan Wang, Can Wang, Zhu Qiu, Tingxiu Xiang, Yunmei Zhang and Weiyan Peng
    Citation: Respiratory Research 2019 20:106
  8. To date there are no head-to-head studies comparing different mucolytic/antioxidant agents. Considering the inconsistent evidence resulting from the pivotal studies on mucolytic/antioxidant agents tested in ch...

    Authors: Paola Rogliani, Maria Gabriella Matera, Clive Page, Ermanno Puxeddu, Mario Cazzola and Luigino Calzetta
    Citation: Respiratory Research 2019 20:104
  9. Surveys and retrospective studies of patients with idiopathic pulmonary fibrosis (IPF) have shown a significant diagnostic delay. However, the causes and risk factors for this delay are not known.

    Authors: Nils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, Torgny Wilcke and Saher Burhan Shaker
    Citation: Respiratory Research 2019 20:103
  10. Bronchopulmonary dysplasia (BPD) is a risk factor for respiratory disease in adulthood. Despite the differences in underlying pathology, patients with a history of BPD are often treated as asthmatics. We hypot...

    Authors: Petra Um-Bergström, Jenny Hallberg, Melvin Pourbazargan, Eva Berggren-Broström, Giovanni Ferrara, Maria J. Eriksson, Sven Nyrén, Jing Gao, Gunnar Lilja, Anders Lindén, Åsa M. Wheelock, Erik Melén and C. Magnus Sköld
    Citation: Respiratory Research 2019 20:102
  11. The mechanisms underlying airflow obstruction in COPD cannot be distinguished by standard spirometry. We ascertain whether mathematical modeling of airway biomechanical properties, as assessed from spirometry,...

    Authors: Mariaelena Occhipinti, Matteo Paoletti, Brian J. Bartholmai, Srinivasan Rajagopalan, Ronald A. Karwoski, Cosimo Nardi, Riccardo Inchingolo, Anna R. Larici, Gianna Camiciottoli, Federico Lavorini, Stefano Colagrande, Vito Brusasco and Massimo Pistolesi
    Citation: Respiratory Research 2019 20:101
  12. Cachexia is associated with increased mortality risk among chronic obstructive pulmonary disease (COPD) patients. However, low body mass index (BMI) as opposed to cachexia is often used, particularly when calc...

    Authors: Merry-Lynn N. McDonald, Emiel F. M. Wouters, Erica Rutten, Richard Casaburi, Stephen I. Rennard, David A. Lomas, Marcas Bamman, Bartolome Celli, Alvar Agusti, Ruth Tal-Singer, Craig P. Hersh, Mark Dransfield and Edwin K. Silverman
    Citation: Respiratory Research 2019 20:100
  13. Recurrent and persistent infections are known to affect airways of patients with Primary Immunodeficiency despite appropriate replacement immunoglobulin serum levels. Interestingly, patients with Chronic Obstr...

    Authors: Cédric Vonarburg, Marius Loetscher, Martin O. Spycher, Alain Kropf, Marlies Illi, Sharon Salmon, Sean Roberts, Karin Steinfuehrer, Ian Campbell, Sandra Koernig, Joseph Bain, Monika Edler, Ulrich Baumann, Sylvia Miescher, Dennis W. Metzger, Alexander Schaub…
    Citation: Respiratory Research 2019 20:99
  14. Pre-bronchodilator lung function including forced vital capacity (FVC), forced expiratory flow in 1 second (FEV1), their ratio (FEV1/FVC), and forced expiratory flow 25–75% (FEF25–75) measured at age 10, 18, and ...

    Authors: Wilfried Karmaus, Nandini Mukherjee, Vimala Devi Janjanam, Su Chen, Hongmei Zhang, Graham Roberts, Ramesh J. Kurukulaaratchy and Hasan Arshad
    Citation: Respiratory Research 2019 20:98
  15. We recently showed that intravenous sodium nitroprusside treatment (SNP) could relieve the pulmonary vasospasm of pulmonary embolism (PE) and non-pulmonary embolism (non-PE) regions in a rabbit massive pulmona...

    Authors: Yuting Wang, Delong Yu, Yijun Yu, Wusong Zou, Xiaohui Zeng, Liqun Hu and Ye Gu
    Citation: Respiratory Research 2019 20:97
  16. Nitric oxide is a mediator of potential importance in numerous physiological and inflammatory processes in the lung. Aminoguanidine (AG) has been shown to have anti-inflammation and radical scavenging properti...

    Authors: Saeideh Saadat, Farimah Beheshti, Vahid Reza Askari, Mahmoud Hosseini, Nema Mohamadian Roshan and Mohammad Hossein Boskabady
    Citation: Respiratory Research 2019 20:96
  17. Asthma is a heterogeneous chronic airway disease, which may be classified into different phenotypes. YKL-40 is a chitin-binding glycoprotein with unclear functions, but its expression is associated with inflam...

    Authors: Lei Liu, Xin Zhang, Ying Liu, Li Zhang, Jing Zheng, Ji Wang, Philip M. Hansbro, Lei Wang, Gang Wang and Alan Chen-Yu Hsu
    Citation: Respiratory Research 2019 20:95
  18. Tobacco smoke exposure impairs the lung’s innate immune response, leading to an increased risk of chronic infections. SPLUNC1 is a secreted, multifunctional innate defense protein that has antimicrobial activi...

    Authors: Patrick J. Moore, Juliana Sesma, Neil E. Alexis and Robert Tarran
    Citation: Respiratory Research 2019 20:94
  19. One of the known weaknesses of spirometry is its dependence on patients’ cooperation, which can only partially be alleviated by educational efforts. Therefore, procedures less dependent on cooperation might be...

    Authors: Christina Kellerer, Neele Jankrift, Rudolf A. Jörres, Klaus Klütsch, Stefan Wagenpfeil, Klaus Linde and Antonius Schneider
    Citation: Respiratory Research 2019 20:92
  20. Wheezing among children below the age of six (pre-schoolers) is common and often triggered by environmental factors. Moreover, evidence on which to base recommendations for its management is limited, resulting...

    Authors: Sonia Trabelsi, Lidia Casas, Benoit Nemery, Tim S. Nawrot and Isabelle Thomas
    Citation: Respiratory Research 2019 20:90
  21. The burden of symptoms and risk of exacerbations are the main drivers of the overall assessment of the Chronic Obstructive Pulmonary Disease (COPD) and the adequate treatment approaches per current Global Init...

    Authors: Florin Mihaltan, Yochai Adir, Adam Antczak, Konstantinos Porpodis, Vesna Radulovic, Nuno Pires, Geeuwke Jan de Vries, Andreas Horner, Samuel De Bontridder, Yunqin Chen, Anat Shavit, Silviu Alecu and Lukasz Adamek
    Citation: Respiratory Research 2019 20:89
  22. While additional oxygen supply is often required for the survival of very premature infants in intensive care, this also brings an increasing risk of progressive lung diseases and poor long-term lung outcomes....

    Authors: Stefanie Endesfelder, Evelyn Strauß, Till Scheuer, Thomas Schmitz and Christoph Bührer
    Citation: Respiratory Research 2019 20:88
  23. Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by aberrant fibroblast activation and progressive fibrotic remodelling of the lungs. Though the exact pathophysiological mechani...

    Authors: Eva Schruf, Victoria Schroeder, Christian A. Kuttruff, Sabine Weigle, Martin Krell, Maryke Benz, Tom Bretschneider, Alexander Holweg, Michael Schuler, Manfred Frick, Paul Nicklin, James P. Garnett and Mirko C. Sobotta
    Citation: Respiratory Research 2019 20:87
  24. Platelet count is a prognostic indicator in the general population and elderly. Thrombocytosis during acute exacerbation of COPD (AECOPD) has been associated with mortality; however, the relationship between p...

    Authors: Ashraf Fawzy, Julie A. Anderson, Nicholas J. Cowans, Courtney Crim, Robert Wise, Julie C. Yates and Nadia N. Hansel
    Citation: Respiratory Research 2019 20:86
  25. Although bronchodilator inhaler therapy can improve lung function in patients with tuberculous destroyed lung (TDL), its effect on mortality has not been studied. We evaluated the effect of tiotropium inhaler ...

    Authors: Ho Cheol Kim, Tae Hoon Kim, Ye-Jee Kim, Chin Kook Rhee and Yeon-Mok Oh
    Citation: Respiratory Research 2019 20:85
  26. Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with high morbidity and mortality. The most important pathophysiological change of COPD is airway obstruction. Airway obstruction ca...

    Authors: Yidan Ren, Yi Zhang, Lixia Fan, Qinlian Jiao, Yunshan Wang and Qin Wang
    Citation: Respiratory Research 2019 20:84

    The Correction to this article has been published in Respiratory Research 2023 24:188

  27. An inverse relationship between oral corticosteroid (OCS) dose and peripheral blood eosinophil (PBE) count is widely recognized in patients with severe eosinophilic asthma; however, there are limited data avai...

    Authors: Charlene M. Prazma, Elisabeth H. Bel, Robert G. Price, Eric S. Bradford, Frank C. Albers and Steven W. Yancey
    Citation: Respiratory Research 2019 20:83
  28. Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Antibiotics are losing their effectiveness due to the emerging infectious diseases, the scarcity of novel antibiotics...

    Authors: Yali Zheng, Pu Ning, Qiongzhen Luo, Yukun He, Xu Yu, Xiaohui Liu, Yusheng Chen, Xiaorong Wang, Yu Kang and Zhancheng Gao
    Citation: Respiratory Research 2019 20:82
  29. Although feelings of anxiety and depression are common in patients with chronic obstructive pulmonary disease (COPD), little is known about the estimates of their incidence in patients with asthma-COPD overlap...

    Authors: Hye-Rim Kang, Sung-Hyun Hong, So-Young Ha, Tae-Bum Kim and Eui-Kyung Lee
    Citation: Respiratory Research 2019 20:80
  30. C-X-C chemokine receptor type 4 (CXCR4) may be involved in the development of pulmonary arterial hypertension (PAH). CXCR4 inhibitor AMD3100 was described to have a positive effect on the prevention of pulmona...

    Authors: Tingting Zhang, Nanako Kawaguchi, Kenji Yoshihara, Emiko Hayama, Yoshiyuki Furutani, Kayoko Kawaguchi, Takeshi Tanaka and Toshio Nakanishi
    Citation: Respiratory Research 2019 20:79
  31. In Cystic Fibrosis (CF), exercise ventilatory inefficiency and dynamic hyperinflation (DH) cause exercise limitation and induce poor exercise tolerance. High-resolution computed tomography (HRCT) of the lung c...

    Authors: Ernesto Crisafulli, Elisabetta Teopompi, Silvia Luceri, Francesco Longo, Panagiota Tzani, Paolo Pagano, Antonella Ielpo, Chiara Longo, Marcello Di Paolo, Nicola Sverzellati, Paolo Palange, Alfredo Chetta and Giovanna Pisi
    Citation: Respiratory Research 2019 20:78
  32. Decreased airway lumen size and increased lung volume are major structural changes in chronic obstructive pulmonary disease (COPD). However, even though the outer wall of the airways is connected with lung par...

    Authors: Naoya Tanabe, Susumu Sato, Tsuyoshi Oguma, Hiroshi Shima, Atsuyasu Sato, Shigeo Muro and Toyohiro Hirai
    Citation: Respiratory Research 2019 20:77
  33. Exposure to fine particulate matter (PM2.5) has been associated with respiratory morbidity and mortality. Identification of interventional measures that are efficacious against PM2.5-induced toxicity may provide ...

    Authors: Juan Li, Hang Li, Haibin Li, Weili Guo, Zhen An, Xiang Zeng, Wen Li, Huijun Li, Jie Song and Weidong Wu
    Citation: Respiratory Research 2019 20:76
  34. It is not known if the endogenous surfactant pool available early in life is associated with the RDS clinical course in preterm neonates treated with CPAP. We aim to clarify the clinical factors affecting surf...

    Authors: Roberto Raschetti, Roberta Centorrino, Emmanuelle Letamendia, Alexandra Benachi, Anne Marfaing-Koka and Daniele De Luca
    Citation: Respiratory Research 2019 20:75
  35. Pulmonary vascular abnormalities are a characteristic feature of chronic obstructive pulmonary disease (COPD). Cigarette smoking is the most important risk factor for COPD. It is believed that its constant exp...

    Authors: Olga Tura-Ceide, Sandra Pizarro, Jéssica García-Lucio, Josep Ramírez, Laureano Molins, Isabel Blanco, Yolanda Torralba, Marta Sitges, Cristina Bonjoch, Victor I. Peinado and Joan Albert Barberà
    Citation: Respiratory Research 2019 20:74
  36. N-acetylcysteine is a classic mucolytic agent. This study aimed to investigate the efficacy of N-acetylcysteine on reducing the risk of exacerbations in bronchiectasis patients.

    Authors: Qian Qi, Yirepanjaing Ailiyaer, Ruijuan Liu, Yan Zhang, Caiyu Li, Mingtao Liu, Xiuxiu Wang, Lijun Jing and Yu Li
    Citation: Respiratory Research 2019 20:73
  37. Asthma exacerbations evoke emergency room visits, progressive loss of lung function and increased mortality. Environmental and industrial toxicants exacerbate asthma, although the underlying mechanisms are unk...

    Authors: Joseph Jude, Danielle Botelho, Nikhil Karmacharya, Gao Yuan Cao, William Jester and Reynold A. Panettieri Jr
    Citation: Respiratory Research 2019 20:72
  38. Given the broad definition of an acute exacerbation of IPF, it is likely that acute exacerbations are heterogeneous in their aetiology, severity and clinical course. We used pooled data from the INPULSIS® tria...

    Authors: Michael Kreuter, Harald Koegler, Matthias Trampisch, Silke Geier and Luca Richeldi
    Citation: Respiratory Research 2019 20:71
  39. Cigarette smoking is one of the major risk factors for the development of chronic obstructive pulmonary disease (COPD). Evidence is accumulating that Receptor for Advanced Glycation-End products (RAGE)-signali...

    Authors: Alen Faiz, Maarten van den Berge, Cornelis J. Vermeulen, Nick H. T. ten Hacken, Victor Guryev and Simon D. Pouwels
    Citation: Respiratory Research 2019 20:70
  40. Among patients with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) is a common comorbidity and is probably associated with increased systemic inflammation and worse prognosis. Metformin, ...

    Authors: Te-Wei Ho, Chun-Ta Huang, Yi-Ju Tsai, Angela Shin-Yu Lien, Feipei Lai and Chong-Jen Yu
    Citation: Respiratory Research 2019 20:69
  41. The study by Kiranantawat et al. “Clinical role, safety and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation” highlights how “pulmonary consolidation...

    Authors: Marco Sperandeo, Anna Del Colle, Elisabettamaria Frongillo, Gaetano Rea, Lucia Dimitri, Cristiana Cipriani and Donato Lacedonia
    Citation: Respiratory Research 2019 20:68
  42. Obstructive sleep apnea hypopnea syndrome (OSAHS) is a sleep-related breathing disorder, characterized by excessive daytime sleepiness (EDS), paralleled by intermittent collapse of the upper airway. EDS may be...

    Authors: Csaba E. More, Csaba Papp, Szilvia Harsanyi, Rudolf Gesztelyi, Angela Mikaczo, Gabor Tajti, Laszlo Kardos, Ildiko Seres, Hajnalka Lorincz, Krisztina Csapo and Judit Zsuga
    Citation: Respiratory Research 2019 20:67
  43. Interferon gamma (IFN-γ) is a clinically relevant immunomodulatory cytokine that has demonstrated significant potential in the treatment and management of respiratory diseases such as tuberculosis and pulmonar...

    Authors: Louise Sweeney, Alice P. McCloskey, Gerard Higgins, Joanne M. Ramsey, Sally-Ann Cryan and Ronan MacLoughlin
    Citation: Respiratory Research 2019 20:66
  44. Multiple gene expression studies have been performed separately in peripheral blood, lung, and airway tissues to study COPD. We performed RNA-sequencing gene expression profiling of large-airway epithelium, al...

    Authors: Jarrett D. Morrow, Robert P. Chase, Margaret M. Parker, Kimberly Glass, Minseok Seo, Miguel Divo, Caroline A. Owen, Peter Castaldi, Dawn L. DeMeo, Edwin K. Silverman and Craig P. Hersh
    Citation: Respiratory Research 2019 20:65
  45. A growing number of studies clearly demonstrate a substantial association between chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD), although little is known about the shared genet...

    Authors: Zhaozhong Zhu, Xiaofang Wang, Xihao Li, Yifei Lin, Sipeng Shen, Cong-Lin Liu, Brain D. Hobbs, Kohei Hasegawa, Liming Liang, H. Marike Boezen, Carlos A. Camargo Jr, Michael H. Cho and David C. Christiani
    Citation: Respiratory Research 2019 20:64
  46. Identifying subjects with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation and mortality is key to aid individual management of COPD. The only FDA approved blood-based drug development...

    Authors: Sarah Rank Rønnow, Jannie Marie Bülow Sand, Lasse Løcke Langholm, Tina Manon-Jensen, Morten Asser Karsdal, Ruth Tal-Singer, Bruce E. Miller, Jørgen Vestbo and Diana Julie Leeming
    Citation: Respiratory Research 2019 20:63
  47. This cohort study of patients with chronic obstructive pulmonary disease (COPD) was performed to evaluate the status of inhaled corticosteroid (ICS) prescriptions following the 2017 revision of the Global Init...

    Authors: Se Hee Lee, Ji-Hyun Lee, Ho Il Yoon, Hye Yun Park, Tae-Hyung Kim, Kwang Ha Yoo, Yeon-Mok Oh, Ki Suk Jung, Sang-Do Lee and Sei Won Lee
    Citation: Respiratory Research 2019 20:62

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.9 - 5-year Impact Factor
    1.444 - SNIP (Source Normalized Impact per Paper)
    1.753 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    105 days submission to accept (Median)

    2023 Usage 
    2,949,876 downloads
    2,397 Altmetric mentions